- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01684670
Intensive Dysarthria Sessions in Adults and Children With Down Syndrome
November 22, 2016 updated by: Duke University
This research study is designed to investigate the feasibility and treatment effects of a behavioral speech treatment in adults and children with Down Syndrome (DS) and dysarthria.
The speech sessions will provide an intensive, articulation-based intervention focused on increasing effort during speech production via use of "clear speech."
A single subject multiple baselines across subjects design will be employed in a total of six subjects divided into two groups of three.
Changes in dependent measures will be determined by visual inspection, effect size determination, and time series analysis.
The study follows accepted procedures in rehabilitation treatment and research and there are minimal foreseeable risks associated with participation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults and children with Downs Syndrome and dysarthria
- Ages 8 years and older
- Ability to verbally communicate; follow simple commands and/or imitate others; hear speech at a conversational level; and participate in assessment and speech sessions activities
Exclusion Criteria:
- Additional serious medical problems which prevent meaningful participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral speech treatment
|
Subjects will be instructed to use clear speech and increased effort when speaking.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speech intelligibility
Time Frame: 3-6 months
|
Speech intelligibility in sentences scored by naive listeners.
|
3-6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Harrison N Jones, PhD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
September 11, 2012
First Submitted That Met QC Criteria
September 11, 2012
First Posted (Estimate)
September 13, 2012
Study Record Updates
Last Update Posted (Estimate)
November 23, 2016
Last Update Submitted That Met QC Criteria
November 22, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Intellectual Disability
- Abnormalities, Multiple
- Chromosome Disorders
- Language Disorders
- Communication Disorders
- Speech Disorders
- Articulation Disorders
- Syndrome
- Down Syndrome
- Dysarthria
Other Study ID Numbers
- Pro00039730
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
-
Cairo UniversityCompleted
-
Institute of Child HealthCompleted
-
Vanderbilt University Medical CenterNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingSpeech Intelligibility Intervention in Down SyndromeUnited States
-
Marmara UniversityCompletedStair up and Down, Amputation | Amputation,Stair up and DownTurkey
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyeloid Proliferations Associated With Down SyndromeUnited States, Canada, Australia, Puerto Rico
-
Eastern Mediterranean UniversityCompletedDown Syndrome, Trisomy 21Cyprus
-
Institut Jerome LejeuneFondation Jérôme LejeuneCompletedDown Syndrome With and Without Auto Immune AbnormalitiesFrance
Clinical Trials on Speech sessions
-
Hospital de Clinicas de Porto AlegreCompletedOral Cancer | Intelligibility, Speech | Tongue Cancer | Jaw CancerBrazil
-
Idaho State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingSpeech Sound DisorderUnited States
-
New York UniversityEmerson CollegeActive, not recruiting
-
New York UniversityEmerson CollegeActive, not recruitingAutism Spectrum DisorderUnited States
-
New York UniversityEmerson CollegeActive, not recruiting
-
Assistance Publique Hopitaux De MarseilleRecruitingEpilepsy | Temporal Lobe Epilepsy | AnomiaFrance
-
University of MichiganNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingStuttering | Stuttering, Childhood | Stuttering, AdultUnited States
-
Florida State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingParkinson Disease | Dysarthria, HypokineticUnited States
-
National Taiwan University HospitalNot yet recruitingAutism | Language Delay | Speech Disorders in Children
-
Portland VA Medical CenterCompletedHearing Impairment | Memory | Auditory PerceptionUnited States